COMPANY
Laurentide Therapeutics Inc.
Pharmaceutical company (SEC Form D industry: Pharmaceuticals); no public description yet. Source · checked Oct 14, 2026
Sourced facts
Funding (SEC filing)
- SEC Form D filed Sep 28, 2026: $99,999 sold · sec.gov · checked Oct 14, 2026
Funding and NIH signals
- SEC Form D raise Raised $100K (Form D filed Sep 28, 2026). SEC Form D 0002157396-26-000001 (Sep 28, 2026)
Evidence (1 event)
- Sep 28, 2026 · SEC Form D 0002157396-26-000001
Name of Issuer: Laurentide Therapeutics Inc.; CIK: 2157396; Address: Atlanta, GA; Submission type: D; Filing date: 2026-09-28; Industry Group: Pharmaceuticals; Date of First Sale: 2026-08-20; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 100000; Total Amount Sold: 99999; Federal exemptions: 06b
- Sep 28, 2026 · SEC Form D 0002157396-26-000001